En Li,
Head of Biomedical Research
Dr. En Li is Head of China Novartis Institutes for BioMedical Research based in Shanghai where he leads epigenetics research and drug discovery for cancer, liver disease, and regenerative medicine. He joined Novartis Institutes for BioMedical Research in Cambridge, Massachusetts in 2003. Prior to that, he was Associate Professor of Medicine at Harvard Medical School and member of the Cardiovascular Research Center and Cancer Research Center of Massachusetts General Hospital in Boston. He has been studying DNA methylation and histone modifications in development and disease. His current research interest includes cancer epigenetics, aging and regeneration.
|
|
|
